Another hypermethylated gene is KCNC1, whose downregulation was able to predict poor survival in seminoma patients and was suggested as a diagnostic biomarker as well as a therapeutic target after being identified through TCGA and confirmed seminoma cell lines [63]. The gene discussed is KCNC1; the disease is seminoma.